Exploring New Models for Cardiovascular Risk Reduction: The Heart Outcomes Prevention and Evaluation 4 (HOPE 4) Canada Pilot Study
- PMID: 33778443
- PMCID: PMC7984976
- DOI: 10.1016/j.cjco.2020.10.006
Exploring New Models for Cardiovascular Risk Reduction: The Heart Outcomes Prevention and Evaluation 4 (HOPE 4) Canada Pilot Study
Abstract
Background: There is a gap between evidence and practice in the management of cardiovascular (CV) risk. Previous research indicated benefits from community-based, multi-faceted interventions to screen, diagnose, and manage CV risk in people with hypertension.
Methods: The Heart Outcomes Prevention and Evaluation 4 Canada pilot study (HOPE 4) was a quasi-experimental pre-post interventional study, involving one community each in Hamilton, Ontario and Surrey, British Columbia, Canada. Individuals aged ≥50 years with newly diagnosed or poorly controlled hypertension were included. The intervention was comprised of: (i) simplified diagnostic/treatment algorithms implemented by community health workers (firefighters in British Columbia and community health workers in Ontario) guided by decision support and counselling software; (ii) recommendations for evidence-based CV medications and lifestyle modifications; and (iii) support from family/friends to promote healthy behaviours. The intervention was developed as part of the international Heart Outcomes Prevention and Evaluation 4 Canada pilot study trial and adapted to the Canadian context. The primary outcome was the change in Framingham Risk Score 10-year CV disease risk estimate between baseline and 6 months.
Results: Between 2016 and 2017, a total of 193 participants were screened, with 37 enrolled in Surrey, and 19 in Hamilton. Mean age was 69 years (standard deviation 11), with 54% female, 27% diabetic, and 73% with a history of hypertension. An 82% follow-up level had been obtained at 6 months. Compared to baseline, there were significant improvements in the Framingham Risk Score 10-year risk estimate (30.6% vs 24.7%, P < 0.01), and systolic blood pressure (153.1 vs 136.7 mm Hg, P < 0.01). No significant changes in lipids or healthy behaviours were noted.
Conclusions: A comprehensive approach to health care delivery, using a community-based intervention with community health workers, supported by mobile-health technologies, has the potential to significantly reduce cardiovascular risk, but further evaluation is warranted.
Contexte: Il existe un écart entre les données probantes et la pratique en matière de prise en charge du risque cardiovasculaire (CV). Les résultats d’études antérieures montrent que des interventions à volets multiples en milieu communautaire visant à dépister, à diagnostiquer et à prendre en charge le risque CV chez les personnes atteintes d’hypertension peuvent être bénéfiques.
Méthodologie: L’étude pilote HOPE4 (Heart Outcomes Prevention and Evaluation 4 Canada) était une étude interventionnelle quasi expérimentale évaluant des patients avant et après certaines interventions, menée au sein de deux communautés canadiennes, l’une située à Hamilton, en Ontario et l’autre à Surrey, en Colombie-Britannique. L’étude réunissait des participants âgés de 50 ans ou plus venant de recevoir un diagnostic d’hypertension ou souffrant d’hypertension mal maîtrisée. Les interventions comprenaient : i) l’utilisation d’algorithmes de diagnostic et de traitement simplifiés par les intervenants en santé du milieu communautaire (pompiers en Colombie-Britannique et agents de santé communautaire en Ontario), à l’aide d’un logiciel d’aide à la décision et de counselling; ii) la formulation de recommandations fondées sur des données probantes concernant la prise de médicaments et l’adoption d’habitudes de vie favorisant la santé CV; et iii) la sollicitation du soutien des membres de la famille et des amis afin de promouvoir l’adoption de comportements favorisant la santé. Ces interventions ont été mises au point dans le cadre de l’étude pilote internationale HOPE4 et adaptées au contexte canadien. Le critère d’évaluation principal était la variation du score de risque de Framingham, qui estime le risque de maladie CV à 10 ans, entre le début et le 6e mois de l’étude.
Résultats: De 2016 à 2017, un nombre total de 193 participants ont été soumis au processus de sélection; 37 patients du centre de Surrey et 19 patients du centre de Hamilton ont été admis à l’étude. L’âge moyen des participants était de 69 ans (écart-type : 11 ans); 54 % d’entre eux étaient des femmes, 27 % étaient atteints de diabète et 73 % avaient des antécédents d’hypertension. Au 6e mois, 82 % des sujets participaient toujours à l’étude. Des améliorations significatives ont été observées comparativement au placebo en ce qui concerne le score de risque de Framingham estimant le risque à 10 ans (30,6 % vs 24,7 %, p < 0,01) et la pression artérielle systolique (153,1 vs 136,7 mmHg, p < 0,01). Aucune variation significative n’a été observée quant à la lipidémie ou aux comportements favorisant la santé.
Conclusions: Une approche exhaustive de la prestation des soins de santé reposant sur des interventions de la part des agents de santé communautaire au moyen de technologies de santé mobiles pourrait aider à réduire significativement le risque CV; une évaluation plus poussée est toutefois nécessaire.
© 2020 Canadian Cardiovascular Society. Published by Elsevier Inc.
Figures



Similar articles
-
A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trial.Lancet. 2019 Oct 5;394(10205):1231-1242. doi: 10.1016/S0140-6736(19)31949-X. Epub 2019 Sep 2. Lancet. 2019. PMID: 31488369 Clinical Trial.
-
Rationale and design of a cluster randomized trial of a multifaceted intervention in people with hypertension: The Heart Outcomes Prevention and Evaluation 4 (HOPE-4) Study.Am Heart J. 2018 Sep;203:57-66. doi: 10.1016/j.ahj.2018.06.004. Epub 2018 Jun 22. Am Heart J. 2018. PMID: 30015069 Clinical Trial.
-
Changes in blood pressure among users of lay health worker or volunteer operated community-based blood pressure programs over time: a systematic review protocol.JBI Database System Rev Implement Rep. 2015 Oct;13(10):30-40. doi: 10.11124/jbisrir-2015-1927. JBI Database System Rev Implement Rep. 2015. PMID: 26571280
-
Canadian Contraception Consensus (Part 1 of 4).J Obstet Gynaecol Can. 2015 Oct;37(10):936-42. doi: 10.1016/s1701-2163(16)30033-0. J Obstet Gynaecol Can. 2015. PMID: 26606712 English, French.
-
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.Can J Cardiol. 2010 May;26(5):249-58. doi: 10.1016/s0828-282x(10)70379-2. Can J Cardiol. 2010. PMID: 20485689 Free PMC article. Review.
Cited by
-
Cardiovascular disease in the Americas: optimizing primary and secondary prevention of cardiovascular disease series: cardiovascular disease in the Americas.Lancet Reg Health Am. 2025 Feb 14;42:100964. doi: 10.1016/j.lana.2024.100964. eCollection 2025 Feb. Lancet Reg Health Am. 2025. PMID: 40034111 Free PMC article. Review.
-
Refining a primary care shared decision-making aid for lifestyle change: a mixed-methods study.BJGP Open. 2022 Mar 22;6(1):BJGPO.2021.0100. doi: 10.3399/BJGPO.2021.0100. Print 2022 Mar. BJGP Open. 2022. PMID: 34853008 Free PMC article.
-
Lay advisor interventions for hypertension outcomes: A Systematic Review, Meta-analysis and a RE-AIM evaluation.Front Med (Lausanne). 2024 May 20;11:1305190. doi: 10.3389/fmed.2024.1305190. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38831986 Free PMC article.
-
Task-sharing with community health workers to treat hypertension: a scoping review.J Hypertens. 2024 Dec 1;42(12):2041-2054. doi: 10.1097/HJH.0000000000003834. Epub 2024 Sep 18. J Hypertens. 2024. PMID: 39469922 Free PMC article.
-
Adherence to Cardiovascular Prevention Guidelines in an Academic Centre.CJC Open. 2023 Mar 23;5(7):530-536. doi: 10.1016/j.cjco.2023.03.010. eCollection 2023 Jul. CJC Open. 2023. PMID: 37496787 Free PMC article.
References
-
- Statistics Canada Ten leading causes of death by selected age groups, by sex, Canada—all ages. https://www150.statcan.gc.ca/n1/pub/84-215-x/2012001/tbl/t001-eng.htm Available at:
-
- World Health Organization (WHO) World Health Organization; Geneva: 2011. Global Status Report on Non-Communicable Diseases 2010.
-
- Lloyd-Jones D.M., Leip E.P., Larson M.G. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation. 2006;113:791–798. - PubMed
-
- Yusuf S., Islam S., Chow C.K. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet. 2011;378:1231–1243. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous